Literature DB >> 22958285

Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolates.

Jan Olsson1, Sabina Davidsson, Magnus Unemo, Paula Mölling, Swen-Olov Andersson, Ove Andrén, Bo Söderquist, Mats Sellin, Fredrik Elgh.   

Abstract

The aim of this study was to determine antibiotic susceptibility of Propionibacterium acnes isolates from prostate. Prostate-derived P. acnes isolates (n = 24, Umeå & Örebro, Sweden, 2007-2010) and a panel of control strains (n = 25, Sweden) collected from skin and deep infections were assessed for resistance to penicillin G, piperacillin-tazobactam, imipenem, gentamicin, azithromycin, erythromycin, vancomycin, ciprofloxacin, moxifloxacin, tetracycline, tigecycline, fusidic acid, clindamycin, rifampicin, linezolid, daptomycin, trimethoprim-sulfamethoxazole, and metronidazole. In addition, the isolates were tested for inducible clindamycin resistance. All prostate derived P. acnes isolates displayed wild-type distribution of MIC-values, without evidence of acquired resistance. In the reference panel, 5 of 25 isolates had acquired macrolide resistance with cross-resistance to azithromycin, clindamycin, and erythromycin. In addition, one of these isolates was resistant to tetracycline.
© 2012 The Authors APMIS © 2012 APMIS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22958285     DOI: 10.1111/j.1600-0463.2012.02905.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  8 in total

Review 1.  Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.

Authors:  Yvonne Achermann; Ellie J C Goldstein; Tom Coenye; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 2.  Clinical and Biological Features of Cutibacterium (Formerly Propionibacterium) avidum, an Underrecognized Microorganism.

Authors:  Stéphane Corvec
Journal:  Clin Microbiol Rev       Date:  2018-05-30       Impact factor: 26.132

3.  Calcium sulphate mixed with antibiotics does not decrease efficacy against Cutibacterium acnes (formerly Propionibacterium acnes), in vitro study.

Authors:  Anne Couture; Valéry Lavergne; Emilie Sandman; Jean-Michel Leduc; Benoit Benoit; Stéphane Leduc; Dominique M Rouleau
Journal:  J Orthop       Date:  2019-11-28

4.  The opportunistic pathogen Propionibacterium acnes: insights into typing, human disease, clonal diversification and CAMP factor evolution.

Authors:  Andrew McDowell; István Nagy; Márta Magyari; Emma Barnard; Sheila Patrick
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

5.  Intrascrotal Abscess, Propionibacterium acnes and Staphylococcus cohnii ssp. cohnii: A Case Report and Review of the Literature.

Authors:  Masciovecchio Stefano; Alessandro Del Rosso; Pietro Saldutto; Giuseppe Paradiso Galatioto; Carlo Vicentini
Journal:  Case Rep Urol       Date:  2012-11-27

6.  Chronic prostatic infection and inflammation by Propionibacterium acnes in a rat prostate infection model.

Authors:  Jan Olsson; Johanna Bergh Drott; Lovisa Laurantzon; Oscar Laurantzon; Anders Bergh; Fredrik Elgh
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

7.  Propionibacterium acnes Augments Antitumor, Anti-Angiogenesis and Immunomodulatory Effects of Melatonin on Breast Cancer Implanted in Mice.

Authors:  Wamidh H Talib; Suhair Saleh
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

8.  Prosthetic valve endocarditis caused by Propionibacterium species: a national registry-based study of 51 Swedish cases.

Authors:  Fredrik Lindell; Bo Söderquist; Kristina Sundman; Lars Olaison; Jan Källman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-29       Impact factor: 3.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.